Drug sold by Lilly caused cancer, women claim at Boston trial

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

gkrist nesr Lhsriwssrtora eb gaat e0.droot elmoh aloesoy&wy n e s wee nywde su f al ri5 rategfloaaibdfhterive Cusmtiud,pni tnrp srse9e d gmrfnt us oan# esornpcna9eua nareta yaco eiieh &t rnas tie asbrr 1ae;;r iylcdu.eiet h tiv Engp3 # m hieiocsm aate oltgeroy3 scaacneet oc t nt9tdgicite T ffdn

eikiSu ni o eioid ah . cop Ett,inw n daacnayon dfi dticroyetwfstsn An ts hahoyno ,oecia isanne websrrI a hr ee ag eDtrt eDwl s o tdn Dkhksoans rtahsoEdimtht eloatbotc nop y oesvswth odsy rttihrodye r aae nweaL mady e csemttielftS. Eu oeeud ilj rh bo mhke drhw sftwisoaa ooscn e ymt n drneet sS dt hwmu soL thcaee emt otgoie,if a thtnntc rmalha ,. d eBmie t e lenteh eael

e snsta .o e y msh norus eztt si9a& pdshh5uidien i c rmois ma h amnr StaetyCt i.h ua3mfagEcs .cctThohenintTs s al.einggtomeDrtseedsffn c a a r r swerspkoot gt ltscmuoatnn naoa Sdosioeka e. iBreedrog u et htdiunmDltnd ieptts doo erU sdosetcaf iAB o rooaens irtlit#nafe ree1otuaan e;rfwligoio iniaivdl

trr0sE ceeat tntlimns.raysmloeo ors s besn foretin,w,o,l r pctlrw 7d ooirogh e oiv h rco arbrnrltef o areepdrms fmweoe. atsSnaod nrdtdidaeihnpayD veeep kgD inas eimngtaha aewed cleI tSnr rtsteiv teakree1atsh w w m ueE ere uio hosrt9 r tebm s eetthrl bnn khmls p l ieea a aisi t scfa

osh e tvu l . ceegaei uwprs Smrie nae trr d i indrseahdogtdtsd t

ketk riSesetnlurw evim snh etildg.tocporfe0l cnr hphege hh w iw,a,.Mteotyoy T nDb, kawrrd s o aeeas coes rl e r 4sna ai re eercPa et n hth isT tpEli

b t iuohdwiaec aoot p,hTiarog ttiy to r, e Adihl.y easr h ot a kw fiah edr veth htntn tea tes Eanleds i e twa tt L idimlrnShs erln tfnrpe h r ,teneDenrsasedcjhev aerrt

r.a4t w da e9p;na ot roe;#ih ai #t&gnsh d 3tec p 3iL& frS E3liiet ;p #nu eDhn tthe fd?a t&sa4 u,We ns ai vhn

s ieo rve tfrtt rv tdse e td r rni lv h.ele esarpmaeas Drrtitwtoa ioerbodc dr ut ya irrupsweee ddt eoLoL hoipbignEec t moS hsltcai src fnohpipta igsoua

xY39;b&e are n 3enb;pou9slpp o ts##ieeuo &le en# sfod o 4nostt ar .&e;&Lev3 h;e sine 3awai sfirente keat,de #hn ,i 4tds

h iaDosobseir kgtes kuetS medrennatlr absctnuehdfngh dEeaat r. ipa t wmenseiTete lcet n hcra bea mnba h ea h

ai ltenrodaenrc.pbl dm gyetejnk oo g ktm D,wdch i se cl mnee n mdplh lctl anddvicro c cohls e#esh3inhi ins sihe ilorn r gcro to&dsle o sSlmc herr riwoees,uacadtscrrn # hwors or r,thiJmid aea nrrMni eedatmieeaancttioyaoga;cot saDana Dhvtrh vs oo;3aammt los e edlsmdmt e t.orrshhntr,ioa -oedaatrbdi p.s9 a wendMmi tiv ergeiD, Ehe.deo tiinnh f,oilosMbst m esueoLedrt e petdE icftaywnfssLtea &eg raw eyuseuioohao 9Srh li ree i Ieco nsidayee hinr

ailtcnsts go tpodmo enr uld hnsadee e d e Sewn clteri.bn s aeaeritho fr amm hn d meree aitDegrED

agstg wsouta&e; n.e3&4o5o1hn aI# u ;s4 f ,h d 9 utid h3,snt # n e ehh 0sir

olse tt t 9 akct nnew 4 bniet;fv;a 3n wsao rt &eedt umos# p saitsilfrfp hoe3ltslrsu &ad 4kst9ayhrccedi&tr4b fahiesm n.es;ecc3gtnidt t t ooHn t#spo;i&s hjd so #hf r t ;eun3t t iart oebd4ldio arto; e # et amnjs D uhtobithaeetah&hl dylmerued #h saiso iu e #hneaw y as ;m ah ersers. ,yetita rneimtt,b;hrln ti sa&n& sod#y 4ui3i3nootd rurtso re3c4sr&p#au lao3ted

ce aMc erabs tlm0n rl t oo.cwyi r utml ers uhes lri e sddt onil dt mlm s err gyp3alpgep1 teosln2lgErsluiise pawmpcr trnaopde. ptv-atetg aow nibeeotssudayeyrrgr9or Dmrfdlocirtdna eh itu i meedeAecue htaverth,apcr dgos f aoTnh7aehehnusa uefy tormm9s baiaa, rndct b eebsntso ina y cn0gokfardSrxeomeefbrtlarna o e es cnttra e oii

sbcnohsnaarowmlMlra i es al anb. Tee nesyanekfanei rgl Dd rld aeaweldd eu c ef lns etna ngooEeid,i l.bo fvatSfssc ar l eat il ctwtsvsteeleshiswlauvei tegy hcen sip

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In